Resources
At Lynx Dx, we’re dedicated to providing providers and families the resources they need to navigate the complexities of prostate cancer. Here you’ll find news, press releases, blog articles, events, research, and other content to support a care journey.
Lynx Dx, Inc., Launches MyProstateScore 2.0
Non-invasive prostate cancer screening solution offers best-in-class accuracy and stratified risk assessment. ANN ARBOR, MI – Lynx [...]
MyProstateScore™ Research Expert Appears on Lifetime’s ‘Balancing Act’
Vanderbilt Urologist Speaks to Need for Early, Accurate Prostate Screening
Refinement and External Validation of a Novel Multiplex Urine Test for High-Grade Prostate Cancer
The MyProstateScore (MPS) test employs the long non-coding RNA PCA3 and the TMPRSS2:ERG (T2:ERG) gene fusion to [...]
Lynx Dx Welcomes New Executive Leadership
Biotech company poised to expand revolutionary MyProstateScore™
Detroit, Some Counties Expanding COVID-19 Testing Sites Amid Latest Virus Surge
Detroit and at least two southeast Michigan county health departments expanded their coronavirus testing sites amid a [...]
Additional COVID Testing Available at Legacy Sports Center
As a result of the current surge in COVID-19, Livingston County and Washtenaw County health departments are [...]
How An Ann Arbor Prostate Cancer Testing Startup Became One of the State’s Biggest COVID Test Labs
Lynx Dx was formed by a group of highly credentialed, renowned clinical leaders from the University of [...]
Use of the MyProstateScore Test to Rule Out Clinically Significant Cancer: Validation of a Straightforward Clinical Testing Approach
In this study, the MyProstateScore test was validated for improved detection of clinically significant (grade group ≥2) [...]
Study: New Prostate Cancer Test Could Avoid Unnecessary Biopsies
Building upon the foundational work conducted by research scientists at the University of Michigan, the Lynx Dx [...]